Keynote Speakers

We are glad to announce the following distinguished researchers as keynote speakers for the GlycoBioTec2021:

Lars Bode

Lars Bode

University of California, San Diego, USA
Lars Bode earned his PhD from Giessen University, Germany, studying the effects of Human Milk Oligosaccharides on selectin-mediated cell-cell interaction in the immune system. Since 2003 he has been working as a postdoctoral fellow at the Burnham Institute for Medical Research in La Jolla, California, where he got appointed as Staff Scientist in 2006. In 2009 the University of California, San Diego, School of Medicine, recruited Lars as an Assistant Professor, and later Professor, of Pediatrics in the Division of Neonatology and the Division of Gastroenterology, Hepatology and Nutrition, where Lars has been developing a new research program to elucidate functions and biosynthesis of Human Milk Oligosaccharides. In 2016 Lars was appointed as the inaugural Director of the Larsson-Rosenquist Foundation Mother-Milk-Infant Center of Research Excellence (LRF MOMI CORE) and in January 2017 Lars was appointed as the first Larsson-Rosenquist Foundation Chair of Collaborative Human Milk Research.

Rita Gerardy-Schahn

Rita Gerardy-Schahn

Hannover Medical School, Hannover, Germany
Rita Gerardy-Schahn is professor for Molecular Biology and Biochemistry at the Hannover Medical School. Her responsibilities are research and education. Her research focus is the molecular characterization of enzymes along the (poly)sialylation pathways of mammalian and bacterial cells. Her team identified central factors along these pathways and invested in the establishment of tools, with which (poly)sialoglycans can be specifically recognized and degraded. Her team has established constitutive as well as conditional animal models to analyze the functions of enzymes of interest under complex physiological conditions. Over the past seven years, she refocused her studies at applied sciences aspects involving the exploitation of characterized enzymes for the production of vaccines.
Horst Bierau

Horst Bierau

Merck Serono S.p.A., Rome, Italy
Horst Bierau is a Senior Scientific Advisor and heads the CMC Science & Intelligence group in the Healthcare division of Merck. He has 20 years of experience in biopharmaceutical product development for a variety of disease indications and his research interests focus on CMC development.

Kaspar Locher

Kaspar Locher

ETH Zurich, Zurich, Switzerland
Kaspar Locher studied Chemistry/Biochemistry at the Swiss Federal Institute of Technology (ETH) Zurich. He obtained a PhD in Biochemistry from the University of Basel in 1998, where he pursued studies with Prof. J. Rosenbusch at the Biozentrum. From 1999-2003, he was a post-doctoral researcher with Prof. Douglas Rees at the California Institute of Technology. In 2003, he joined ETH Zurich as an Assistant Professor and was promoted to Full Professor of Molecular Membrane Biology in 2013. Locher is interested in the structural and mechanistic studies of membrane proteins. His research focus includes the investigation of glycosyltransferases that are part of the protein N-glycosylation machinery. His goal is to assemble molecular "movies" of these essential biochemical reactions by combining high resolution protein structures with biochemical and biophysical studies. In addition to generating insight into the mechanism of physiologically important reactions, his studies provide opportunities for future drug discovery.
Pauline Rudd

Pauline Rudd

A*Star, Agency for Science, Technology and Research, Singapore
Pauline M. Rudd (PMR) BSc, LRIC, MA (Oxon), FISSR, PhD is an Emeritus Fellow of the Conway Institute University College Dublin and Visiting Investigator at the Bioprocessing Technology Institute, AStar, Singapore. From 2006-2018 she was NIBRT Professor of Glycoproteomics and Glycobiology at University College, Dublin heading the NIBRT GlycoScience Group. PMR obtained a BSc in Chemistry at the University of London and a PhD in Glycobiology at the Open University, UK. She was a Founding Scientist of Wessex Biochemicals (later Sigma London) and after a long career break to raise 4 children, a member of the Oxford Glycobiology Institute for 25 years and a University Reader. She was a visiting scientist at The Scripps Research Institute, CA, Shanghai Medical University PRC, Ben Gurion University of the Negev, Israel and an Erskine Visiting Fellow, Canterbury University, Christchurch, New Zealand. She is a Fellow of the Royal Society of Medicine, London and a Visiting Professor at St. George’s Hospital, London and an Adjunct Professor at North Eastern University, Boston, Trinity College, Dublin and NUIG Galway. PMR has >370 scientific publications and > 400 talks at international meetings. In 2010 PMR was awarded the James Gregory Medal and an Agilent Thought Leader award, in 2012 she received a Waters Global Innovation Award in NIBRT and in 2017 in BTI AStar Singapore. She received an HD at the Sahlgrenska Institute, Univ. of Gothenburg (2015) and the International Glycoconjugate Organisation Award for contributions to GlycoScience (2017).
Go to Editor View